4565
Nexcera Pharma Co., Ltd.
2026/04/09
Nexcera Pharma has achieved milestone payments up to USD 694 million (approx. JPY 110.9 billion) in its alliance with Eli Lilly, already factored into earnings guidance for the fiscal year ending December 2026.
